Stay updated on Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference5%
- Check22 days agoChange DetectedUpdate to version v3.1.0 with removal of several health topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the page.SummaryDifference0.8%
- Check36 days agoChange DetectedThe page now declares Revision: v3.0.2, replacing v3.0.1, signaling a new release; a 'Back to Top' element was removed, a minor UI change with no impact on core content or availability.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as important topics related to drug safety and muscular dystrophy. Notably, the previous version's references to certain locations and conditions have been removed.SummaryDifference4%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of WVE-210201 in Duchenne Muscular Dystrophy Clinical Trial page.